Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Menelaos Konstantinos Papoutselis"'
Autor:
Panagiotis Diamantopoulos, Dafni Koumbi, Ioannis Kotsianidis, Vasiliki Pappa, Argiris Symeonidis, Athanasios Galanopoulos, Panagiotis Zikos, Helen A. Papadaki, Panayiotis Panayiotidis, Maria Dimou, Eleftheria Hatzimichael, George Vassilopoulos, Susan Delimpasis, Despoina Mparmparousi, Sotirios Papageorgiou, Eleni Variami, Marie‐Christine Kyrtsonis, Aekaterini Megalakaki, Maria Kotsopoulou, Panagiotis Repousis, Ioannis Adamopoulos, Flora Kontopidou, Dimitrios Christoulas, Alexandra Kourakli, Dimitrios Tsokanas, Menelaos Konstantinos Papoutselis, Georgios Kyriakakis, Nora‐Athina Viniou, the Hellenic MDS study group
Publikováno v:
Cancer Medicine, Vol 8, Iss 5, Pp 2056-2063 (2019)
Abstract In patients with myelodysplastic syndrome (MDS), the prognostic significance of chromosome 17 abnormalities has not yet been fully elucidated, except for isochromosome 17q that has been characterized as an intermediate risk abnormality in th
Externí odkaz:
https://doaj.org/article/1ac96392361c45e28bc216058adc8d5a
Autor:
Panagiotis T. Diamantopoulos, Elena Solomou, Argiris Symeonidis, Vasiliki Pappa, Ioannis Kotsianidis, Athanasios Galanopoulos, Charalampos Pontikoglou, Achilles Anagnostopoulos, George Vassilopoulos, Panagiotis Zikos, Eleftheria Hatzimichael, Maria Papaioannou, Aekaterini Megalakaki, Theodoros Vassilakopoulos, Maria Dimou, Dimitrios Tsokanas, Menelaos‐Konstantinos Papoutselis, Sotirios Papageorgiou, Alexandra Kourakli, Helen Papadaki, Panayiotis Panayiotidis, Nora‐Athina Viniou
Publikováno v:
American Journal of Hematology. 98
Autor:
Christina Misidou, Eleni Gkolia, Chrysa Kymparidou, Vasileios Papadopoulos, Menelaos Konstantinos Papoutselis, Konstantinos Liapis, George Vrachiolias, Savvas Deftereos, Dimitrios Stakos, Ioannis Kotsianidis
Publikováno v:
Blood. 140:4094-4095
Autor:
Eleftheria Hatzimichael, Argiris Symeonidis, George Vassilopoulos, Athanasios Galanopoulos, Vasiliki Pappa, Panagiotis Zikos, Menelaos-Konstantinos Papoutselis, Alexandra Kourakli, Dimitrios Tsokanas, Marie-Christine Kyrtshonis, Maria Papaioannou, Achilles Anagnostopoulos, Maria Kotsopoulou, Maria Dimou, Helen A. Papadaki, Aekaterini Megalakaki, Nora-Athina Viniou, Panagiotis T. Diamantopoulos, Panagiotis Repousis, Panayiotis Panayiotidis, Charalampos Pontikoglou, Sotirios G. Papageorgiou, Elena E. Solomou, Ioannis Kotsianidis, Georgios Dryllis
Publikováno v:
British Journal of Haematology. 192:978-987
The regimen of 5-azacytidine for patients with myelodysplastic syndrome (MDS) has remained unchanged since its first approval. Although several modifications have since been made and delays and dose reductions are common especially during the first t
Autor:
Maria Papaioannou, Eleftheria Hatzimichael, Menelaos-Konstantinos Papoutselis, Alexandra Kourakli, George Vassilopoulos, Panayiotis Panayiotidis, Vasiliki Pappa, Helen A. Papadaki, Eleni Solomou, Panagiotis Zikos, Argiris Symeonidis, Nora-Athina Viniou, Sotirios G. Papageorgiou, Georgios Kyriakakis, Maria Dimou, Achilles Anagnostopoulos, Panagiotis T. Diamantopoulos, Athanasios Galanopoulos, Aekaterini Megalakaki, Panagiotis Repousis, Ioannis Kotsianidis, Charalampos Pontikoglou, Maria Kotsopoulou, Dimitrios Tsokanas
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:114-121
Background Hypomethylating agents have altered the prognosis of myelodysplastic syndrome (MDS) so that long-term survival is now a feasible treatment goal. Patients and Methods We analyzed data from patients with MDS treated with 5-azacytidine record